← Back to Search

Molecular Test

Study Groups for Coronavirus Pandemic

N/A

Waitlist Available

Research Sponsored by 3EO Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1-16 weeks

Awards & highlights

Study Summary

This trial tests a home Covid test to check accuracy against current tests. Participants will provide nasal samples for comparison.

Eligible Conditions

Coronavirus Pandemic

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1-16 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1-16 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-16 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Correlation of the 3EO Health SARS-CoV-2 standard of care (PCR) Zymo rRT-PCR results of the anterior nare sample.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Study GroupsExperimental Treatment1 Intervention

Positives: Symptomatic vs. Asymptomatic Negatives: Symptomatic vs. Asymptomatic Each broken down by age groups: 2-14 years old 15-24 years old 25-64 years old 65+ years old

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Diagnostic Test: IN Vitro

2022

N/A

~210

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

3EO HealthLead Sponsor

1 Previous Clinical Trials

64 Total Patients Enrolled

Adelina Paunescu, PhDStudy DirectorMedicept Inc

Jerika AcostaStudy DirectorMedicept Inc

1 Previous Clinical Trials

64 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open enrollment opportunities for this experiment?

"According to information from clinicaltrials.gov, the trial is no longer recruiting patients. After being posted on February 6th 2023 and edited lastly on January 20th 2023, this particular research endeavour has ceased enrolling new participants; however, 858 other studies are still looking for volunteers."

Answered by AI

How many sites are currently administering this research?

"This study is actively enrolling patients at Health Quality Primary Care in Lawrence, Vytalus Medical Atascocita in Humble, and Vytalus Medical in Kingwood. Additionally, there are 4 additional sites with open spots for participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

COVID-19 Molecular OTC At Home Test

2022. "COVID-19 Molecular OTC At Home Test". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05704803.